Quantessence Capital LLC Bio Rad Laboratories, Inc. Transaction History
Quantessence Capital LLC
- $340 Billion
- Q2 2025
A detailed history of Quantessence Capital LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Quantessence Capital LLC holds 2,336 shares of BIO stock, worth $713,788. This represents 0.17% of its overall portfolio holdings.
Number of Shares
2,336Holding current value
$713,788% of portfolio
0.17%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
439Shares Held
19.1MCall Options Held
10.7KPut Options Held
35.5K-
First Eagle Investment Management, LLC2.52MShares$769 Million1.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.79MShares$548 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$474 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1MShares$305 Million0.06% of portfolio
-
Veritas Asset Management LLP844KShares$258 Million2.74% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.53B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...